Chris Bulman’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$353K Buy
+294
New +$300K 0.13% 106
2026
Q1
Sell
-246
Closed -$264K 153
2025
Q4
$264K Buy
+246
New +$235K 0.12% 117
2025
Q3
Sell
-457
Closed -$356K 146
2025
Q2
$356K Sell
457
-61
-12% -$47.4K 0.2% 77
2025
Q1
$428K Buy
518
+174
+51% +$145K 0.27% 71
2024
Q4
$266K Sell
344
-25
-7% -$20.7K 0.17% 99
2024
Q3
$327K Buy
369
+98
+36% +$88.1K 0.22% 75
2024
Q2
$246K Buy
+271
New +$217K 0.17% 84

Other funds holding LLY

Chris Bulman's LLY Position: Q2 2026 in Review

Chris Bulman opened a new position in Eli Lilly (LLY) in Q2 2026: 294 shares worth $353K. The stake represents 0.13% of the portfolio and ranks #106 among its holdings. This is a return to the name: Chris Bulman previously reported a position in LLY as recently as Q4 2025.

Chris Bulman first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. The position peaked at $428K in Q1 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chris Bulman held 294 shares of Eli Lilly worth $353K as of Q2 2026.
  • Eli Lilly was a new Chris Bulman position in Q2 2026.
  • Eli Lilly made up 0.13% of Chris Bulman's portfolio in Q2 2026, its #106 holding.
  • Chris Bulman first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
  • Chris Bulman's Eli Lilly position peaked at $428K in Q1 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chris Bulman's 13F filing for Q2 2026, filed 22 Jul 2026.